Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT03865979 Enrolling by invitation - Clinical trials for Intracerebral Hemorrhage

AI ENRICH - AI Detection of ICH

Start date: January 23, 2020
Phase: N/A
Study type: Interventional

To evaluate the performance of the Viz RECRUIT software in subjects identified as symptomatic of a stroke event as determined by standard of care imaging assessments and interpretation.

NCT ID: NCT03538379 Enrolling by invitation - Hemorrhage Clinical Trials

Tourniquet Training Effectiveness Study

TRIAGE
Start date: April 4, 2018
Phase: N/A
Study type: Interventional

Trauma is the leading cause of death for individuals ages 1-45 years old, within this cohort, and uncontrolled hemorrhage is the leading cause of preventable death.1,2 Tourniquets have been shown to be effective in dramatically decreasing death from uncontrolled hemorrhage on the battlefield and there is level 4 evidence that EMS application of tourniquets in the civilian sector is effective though not to the same degree as in the military.3,4 Multiple national groups have advocated that to further decrease preventable deaths from hemorrhage, laypersons should apply tourniquets before the arrival of professional first responders. To this aim, the "Stop the Bleed" campaign has trained over 100,000 individuals in the US in hemorrhage control techniques and tourniquet use with the Bleeding Control Basic (B-Con) course.5 The "Stop the Bleed" campaign informs course participants all commercial tourniquets are equivalent, and improvised tourniquets should be applied if a commercial tourniquet is not available.6 The investigators are evaluating the ability of the B-Con course participants to apply three different types of commercial tourniquets, the Rapid Application tourniquet (RAT), the Stretch-Wrap-And-Tuck tourniquet (SWAT-T), and the Sof Tourniquet (Sof-T) as well as participants ability to fashion an improvised tourniquet. The investigators hypothesize B-Con in its current form does not enable course participants to apply other commercial tourniquets beyond the specific one taught, the CAT tourniquet, and does not teach how to apply an improvised tourniquet.

NCT ID: NCT03388970 Enrolling by invitation - Clinical trials for Intracerebral Haemorrhage in Cerebellum

Vitamin K1 in the Treatment of Spontaneous Intracerebral Hemorrhage

Start date: August 1, 2017
Phase: Early Phase 1
Study type: Interventional

In order to determine the effectiveness and safety of early vitamin K1 use in reducing the risk of bleeding and improving prognosis in patients with spontaneous intracerebral hemorrhage. Patients with spontaneous intracerebral hemorrhage (excluding rupture of aneurysm and vascular malformation) will be randomly divided into experimental group and control group. All the patients in the two groups were treated according to the guideline of spontaneous intracerebral hemorrhage. Patients in the experimental group was treated with intravenous injection of vitamin K1 20mg once a day for 2 days after admission, and the patients in control group was treated with normal saline as a control. The hematoma volume, coagulation function, platelet levels and GCS scales of the two groups will be recorded in 0d, 1d, 3d, 7d post bleeding stroke, furthermore, length of ICU stay and total hospitalization, incidence of complications during hospitalization are to be recorded. During the follow-up, mRS score will be recorded at 1m and 6m post bleeding stroke.

NCT ID: NCT03234894 Enrolling by invitation - Bleeding Clinical Trials

Clinical Trial of the WC360 SiteSeal Adjunctive Compression Device Following Interventional Endovascular Procedures

SiteSeal
Start date: April 1, 2016
Phase: N/A
Study type: Interventional

This Clinical Study is a pivotal study to evaluate the safety of the SiteSealâ„¢ Adjunctive Compression Device across a broad array of patients undergoing interventional endovascular procedures.

NCT ID: NCT03166163 Enrolling by invitation - Gingival Bleeding Clinical Trials

Evaluation of Bleeding on Brushing Using Neem Extract Mouthwash Versus Chlorhexidine Mouthwash

mouthwash
Start date: May 20, 2017
Phase: N/A
Study type: Interventional

i will compare the effect of neem extract mouthwash versus the chlorhexidine mouthwash on bleeding on brushing among a group of Egyptian children.

NCT ID: NCT03105960 Enrolling by invitation - Gingival Bleeding Clinical Trials

Garlic With Lime Juice and Chlorhexidine Mouthwash

mouthwash
Start date: March 10, 2017
Phase: N/A
Study type: Interventional

the study about herbal mouthwash. it is clinical trial .the investigator will compare between chlorhexidine mouthwash and garlic with lime juice mouthwash.and their effect on gingival bleeding and plaque and salivary bacteria.

NCT ID: NCT02920645 Enrolling by invitation - Clinical trials for Intracerebral Hemorrhage

Multicenter Validation of the AVICH Score

AVICH
Start date: September 2016
Phase: N/A
Study type: Observational

The primary objective of this multicenter study is to validate the AVICH score in terms of patient outcome prediction in AVM patients with associated ICH. Secondary objectives are the impact of pretreatment of the AVICH score. Patients outcome is measured using the modified Rankin Scale (mRS) and are grouped in favorable (mRS score, 0-2) and unfavourable (mRS score, 3-6) outcome at last follow-up (LFU). The following parameters, which are part of the AVICH score, will be compared between the 2 groups: ICH score including age, Glasgow Coma Scale (GCS) score, haemorrhage volume, presence of intraventricular hemorrhage (IVH), and localization of the ICH. Spetzler-Martin grade including AVM size, eloquent location, and venous drainage, as well as the Lawton-Young grade, including age, presence of ruptured AVM, and the nidus structure. In addition pre-/postruptured treatment modalities, including embolization, radiotherapy, surgery or no treatment will be analysed. Outcome (mRS) at 3 months, at 1 year, and at LFU will be compared. Multicentre validation study Key inclusion criteria: - All patients with ICH associated AVMs and a modified Rankin Scale <2 (so 0-1) before hemorrhage - Pretreatment (embolization, radiosurgery, surgery) before ICH is not an exclusion criteria. Key exclusion criteria: - incomplete data set - AVM Patients with only subarachnoid hemorrhage (SAH) or IVH and no ICH

NCT ID: NCT02910115 Enrolling by invitation - Blood Loss Clinical Trials

Cooling the Uterus in C-section After Dysfunctional Labor

Start date: September 2016
Phase: N/A
Study type: Interventional

The objective of the study is to demonstrate whether cooling the uterine smooth muscle during cesarean section (following delivery of the fetus) will promote better uterine contraction and involution resulting in lower blood loss, use of fewer uterotonic medications, and fewer hysterectomies following cesarean section for dysfunctional labor.

NCT ID: NCT02270723 Enrolling by invitation - Clinical trials for Hemorrhage; Complicating Delivery, Coagulation Defect

The Effect of Human Albumin on Coagulation Competence and Hemorrhage

Start date: August 2014
Phase: Phase 4
Study type: Interventional

In a randomized clinical trial, the purpose is to investigate if perioperative coagulation and hemorrhage is influenced by colloid or crystalloid.

NCT ID: NCT02084615 Enrolling by invitation - Clinical trials for Postoperative Complications

Prospective Study Investigating Aspirin and Intraoperative Blood Loss and Complications Following Inguinal Hernia Repair

Start date: August 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether aspirin taken in the perioperative period will increase the blood loss associated with open inguinal hernia repairs. A secondary purpose of this study is to determine if the aspirin administered in the perioperative period increases the risk of complications associated with open inguinal hernia repairs.